As shown in Figure 4D, 6-hour exposure to sudemycin D1 reduced NF-κB p65 activity by 20–30%, showing a moderate bias for the SF3B1-mutated when compared to the -unmutated CLL cases. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.